XASX
RMD
Market cap33bUSD
Sep 17, Last price
32.04AUD
1D
0.44%
1Q
20.09%
Jan 2017
273.43%
Name
Resmed Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1989 and headquartered in San Diego, California, ResMed Inc. stands as a global leader in health technology, specializing in the development, manufacturing, distribution, and marketing of advanced medical devices and sophisticated cloud-based software solutions for the healthcare industry. The company operates through two primary divisions: Sleep and Respiratory Care, and Software as a Service (SaaS). Within its Sleep and Respiratory Care segment, ResMed offers an extensive range of products designed to address various respiratory disorders. These include innovative technologies integrated into both medical and consumer devices, ventilation systems, diagnostic tools, and a variety of mask systems suitable for both hospital and home environments, complete with essential headgear and accessories. The segment also provides dental devices and cloud-based informatics software aimed at improving patient outcomes and streamlining business operations. ResMed's digital portfolio features several specialized platforms. AirView, a cloud-based system, facilitates remote monitoring and adjustment of patient device settings. For individuals managing sleep apnea, myAir is a personalized therapy management application offering vital support, educational resources, and troubleshooting assistance to enhance engagement and treatment adherence. Additionally, U-Sleep provides compliance monitoring solutions that help home medical equipment (HME) providers optimize their sleep programs. Further connectivity options include module and Propeller solutions, alongside the Propeller portal. The company's robust Software as a Service segment delivers a comprehensive suite of out-of-hospital software solutions. Brightree furnishes business management software and services tailored for providers in HME, pharmacy, home infusion, orthotics, and prosthetics. MatrixCare supplies care management and related ancillary solutions to senior living communities, skilled nursing facilities, life plan communities, home health, home care, hospice organizations, and associated accountable care organizations. Furthermore, HEALTHCAREfirst offers electronic health record (EHR) systems, software, billing and coding services, and analytics specifically designed for home health and hospice agencies. ResMed distributes its diverse range of products and services globally to sleep clinics, home healthcare dealers, and hospitals through a broad network of distributors and a dedicated direct sales force, covering approximately 140 countries worldwide.
Related entities
Subsidiaries (2)
ResMed Corp.
RESMED PTY LTD
Key people
Non-Executive Chairman of the Board · since 2014
Chief Executive Officer, Director · since 2013
Brett A. Sandercock
Chief Financial Officer · since 2006
Jim R. Hollingshead
President � Sleep Business · since 2017
Richard McHale
President � Respiratory Care Business · since 2017
President � Software as a Service Business (SaaS) · since 2017
Chief Administrative Officer, Global General Counsel, Secretary · since 2011
Independent Director · since 2013
Independent Director · since 2019
Richard Sulpizio
Independent Director · since 2005
Ronald R. Taylor
Lead Independent Director · since 2013
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
9001 Spectrum Center Blvd.
San Diego, CA 92123
US
San Diego, CA 92123
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||